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Background: Sacral neuromodulation operations have usually been performed based on 2D fluoro images.
However, sacral nerve stimulation lead implantation may be challenging when the normal anatomy is confused by
obesity or congenital anomalies. Thus the surgical navigation and intraoperative imaging methods could be helpful
as those same methods have proven to be feasible methods for guiding other surgical operations. Our recent
knowledge about the O-arm in trauma pelvic operations encouraged us to evaluate the usefulness of O-arm
guided navigation in sacral neuromodulation. Similar navigation would be useful for complex sacral nerve
stimulation lead implantations.
Methods: In this preliminary article we report our experience of utilizing the orthopedically optimized O-arm to
implant the S3 stimulation electrode in a patient. The 3D O-arm imaging was performed intraoperatively under
surgical navigation control. General anesthesia was used. The obtained 3D image dataset was registered
automatically into the patient’s anatomy. The stimulation needle was guided and the tined lead electrode was
implanted using navigation.
Results: The bony sacral structures were clearly visualized. Due to automatic registration, the navigation was
practicable instantly after the O-arm scanning and operation could be performed successfully under navigation
control.
Conclusions: To our knowledge, this is the first published tined lead implantation which was guided based on the
surgical navigation and intraoperative O-arm images. In this case, the applied method was useful and helped the
surgeon to demarcate the region of surgical interest. The method is slightly more invasive than the formal
technique but could be an option in anatomically challenging cases and reoperations. However, further evaluation
with larger patient series is required before definitive recommendations can be made.
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surgery, Intraoperative imagingBackground
Sacral nerve stimulation (neuromodulation) has become a
widely accepted method to treat various urological and
gastrointestinal problems [1]. The technique is based on
the stimulation of sacral nerves, usually S3, through the
sacral foramina. Usually, the localization of the nerves is
easy for an experienced surgeon. In some cases, however,
problems can arise, especially with anomalous sacral anat-
omy or morbid obesity. Recently, complications associated
with sacral neuromodulation for bowel problems were* Correspondence: markku.vaarala@oulu.fi
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reproduction in any medium, provided the orreported [2]. In a literature review, thirty-five incidences
of problems associated with the implanted lead were
detected, including 31 lead displacements/dislodgements/
dislocations/migrations and 4 lead fractures [2]. Earlier,
Siegel and colleagues [3] reported complications among
the 914 test stimulation procedures done on the 581 pa-
tients, where 181 adverse events occurred in 166 of these
procedures (18.2% of the 914 procedures). The vast major-
ity of complications were related to lead migration (108
events, 11.8% of procedures) [3]. Technical advances, such
as the introduction of the tined lead and the two-staged
procedure, appear to have positively affected the adverse
event and reoperation rates [4].ral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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20 years and the benefits are also obvious in some or-
thopedic operations [5]. An earlier publication describes
the use of computed tomography for needle implantation
guidance [6]. To evaluate the usefulness of surgical naviga-
tion in sacral neuromodulation, the O-arm was used for
the implantation of a tined lead electrode in a patient
already needing their third revision.
Methods
Patient
The patient is a 51 year-old female with multiple scler-
osis. She has a neurogenic overactive bladder and severe
constipation. In 2003 the patient underwent peripheral
nerve evaluation (PNE). She saw no improvement in
bladder symptoms but a clear alleviation of constipation,
and underwent implantation using InterStimR. The tined
lead technique and the left S3 were used, and the patient
was satisfied with the operation. Overactive bladder
symptoms were successfully treated with repeated botu-
linum toxin injections; the battery was changed in Janu-
ary 2007. The patient, however, did not have any feeling
of stimulation and a revision was performed in Decem-
ber 2007. The left lying electrode was partially cut and a
new tined lead electrode was placed on the right S3.
During the following years, the patient was satisfied with
stimulation but a high amount of current was needed. In
winter 2011, the battery again was empty. Following X-ray
it was noted that the electrode had moved outwards;
therefore, a new electrode was placed on the right S4 in
the second revision operation. The patient improved
again. In autumn 2012, the patient again reported feeling
no further stimulation and the measured impedances were
over 4000 ohms. Because the patient was satisfied with the
neuromodulation she wanted to have a revision. Due to
the complicated history, already necessitating the
third revision, the O-arm system was considered for
the localization of foramina; the patient accepted the
proposal and the operation was performed in January
2013. General anesthesia was used. Consent to publish her
case was obtained from the patient. The treatment was
conducted according to the Declaration of Helsinki.
The O-arm
The O-arm (Medtronic Inc., Louisville, CO, USA) is a mo-
bile 2D/3D X-ray imaging system optimized for bony
structures in spinal and orthopedic surgery. Scanning is
based on a flat panel detector and cone-beam technology
producing 192 slices in 13 seconds in the standard mode.
Pixel size is 0.415 × 0.415 mm within a slice thickness of
0.833 mm. The size of the scanned cylindrical 3D volume
was 16 cm × 21 cm (length × diameter), which fulfilled
the requirements for obtaining a full scan of the sacrum
(Figure 1A).Surgical table
The patient lay prone on four-point cushions and on a
carbon fiber operating table (Mizuho OSI, Modular
Table System, Union City, CA, USA). The patient’s head
was placed on the soft mask, and slid into the socket of
the C-Flex Polar Head Positioner System (Allen Medical
Systems, Acton, MA, USA), which was fixed to the car-
bon fiber rails (Figure 1B).
Imaging
For the scanning, the patient and the O-arm’s gantry
were positioned so that the sacrum was in the O-arm’s
isocenter; this was verified using lateral and vertical 2D
fluoroimages. The 3D data set were obtained utilizing
the standard mode for the pelvic region with scanning
values for M-size patient. Images were imported auto-
matically to the surgical navigation system.
Surgical navigation
The applied surgical navigation system was StealthStation
S7 (Medtronic Inc., Louisville, CO, USA), which utilizes
the optical localization method. The navigation software
was spine software, which enables automated registration
between the scanned images and patient anatomy. Auto-
mated registration requires a line of sight from the optical
camera to the active O-arm tracker and the passive patient
tracker when scanned. The patient tracker was fixed to
the patient’s left posterior sacral crest using a percutan-
eous pin (Figure 1C).
Procedure
After fixing the pin, the earlier placed and partially cut left
S3 and right S4 electrodes were removed. It had been pre-
viously decided that right S3 was to be used. A foramen
needle was fixed to the patient tracker (Figure 1D). Using
the monitor made it very easy for the urologist to intro-
duce the needle inside the right S3 (Figure 1E and F). Dur-
ing testing an anal contraction was confirmed and a tined
lead was introduced into the foramen. During the oper-
ation, the O-arm did not prevent the surgeon from work-
ing in any way (Figure 1G). With a connection cable, the
electrode was attached to the old InterStimR pulse gener-
ator. The wounds were closed in layers and dressed. The
recovery of the patient was uneventful and she was satis-
fied with the stimulation.
Radiation exposure
During 2D and 3D scanning, the patient was exposed to
ionizing radiation. The 2D fluoroimages were used to cen-
ter the O-arm in the optimal position for 3D-scanning
and verifying the final location of the implanted electrode.
The 3D scan was required for the navigation. In the 2D
mode, total exposure time was 13.51 sec and the radiation
dose was comparable to those when using conventional
Figure 1 Intraoperative figures of sacral nerve stimulator lead implantation. The O-arm is a transportable CT-like scanner. With automated
positioning, it can be easily placed around the patient on the radiolucent table to obtain 2D fluoroscopic images and 3D scanning in desired
directions, and repeated when necessary (A). The patient’s position can be adjusted optimally to achieve a surgically and anesthetically
comfortable situation (B). Patient tracker fixed to the bone (C). The multipurpose SureTrack instrument tracker was fixed to the needle and used
for navigation (D). Needle inside S3, 3D image (E). The sacral structures are clearly visible in the O-arm images; it was possible to guide the
instruments used in the correct direction and to the right depths. Inserts with 2D and a 3D images (F). Lead implantation; the O-arm has been
moved in the cranial direction allowing free access to the operation area (G).
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dose index) was calculated as 14.08 mGy and the DLP
(dose length product) was 225 mGycm. The Finnish Radi-
ation and Nuclear Safety Authority (Säteilyturvakeskus,
STUK) has not yet published the dose limits for the pelvic
CTs. However, radiation doses are quite low com-
pared to the acceptable dose limits in some other
countries in Europe (CTDI: 14 – 35 mGy and DLP:450 – 650 mGycm) [7]. Ionizing radiation doses should be
adjusted using the collimation and limiting 2D area and
by shortening the length of the 3D volume.
Results
The use of the O-arm was fluent. This was possible with
the automated positioning system which did not cover
region of the surgical area. The sacrum and the foramina
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the values of brightness and contrast had to be adjusted.
Due to automatic registration, the navigation was prac-
ticable instantly after the O-arm scanning.
The locations of the skin incision and the trajectory of
the needle could be determined based on the navigation
data as the foramina were well demarcated. During the
operation, the surgeon was able to control the move-
ments of the needle and to find the correct depth for
both the needle and the implanted electrode. The treat-
ment was successful with ongoing very good treatment
response to constipation in September 2013.
Discussion
The technical advances of sacral nerve stimulation testing
phase, namely the use of a tined lead and two phase test-
ing, have improved the results during the last decade [4].
However, the complex anatomical situations may obliter-
ate these advances and can result in increased complica-
tion rates and impaired testing phase results. In the search
for safe techniques and to overcome challenging situa-
tions, the use of navigation for lead implantation during
sacral nerve stimulation was evaluated and found to be
successful. Navigation utilizing the O-arm has been shown
to be useful in spinal trauma surgery, especially in pedicle
screw positioning [8]. To our knowledge, this is the first
report of surgery when navigation has been used in the
implantation of the sacral nerve stimulation lead. In our
clinic, we have performed neuromodulations since 1996,
when the first test was performed; the first implantation
was in September 1997. The Finnish urological patient
material was published in 2011 [9]. One of the authors
(PH) also has some experience of the treatment of fecal in-
continence with neuromodulation and has performed im-
plants in some myelomeningocele patients.
Using anatomical landmarks and fluoroscopy makes it
less difficult to find the foramina [10]. The technique of
sacral nerve stimulation has evolved during recent de-
cades. At first, peripheral nerve evaluation (PNE) was
performed using a very thin temporary electrode [11,12];
later, the use of a tined lead electrode became routine
[13]. Sometimes, however, difficulties can arise in the
localization of the foramina, especially if there are ana-
tomical variations, like in myelomeningocele patients.
We think that navigation using an O-arm could be bene-
ficial in these cases. Lansen-Koch and associates [14]
performed peripheral nerve evaluation for 10 patients
with spina bifida: in two, PNE was not possible, 3/10 pa-
tients had more than 50% improvement and proceeded
to a permanent implant, while in one patient it was
not possible to perform the implantation. The authors
performed an open operation to prevent damage to the
nerves. However, using navigation, open surgery could
probably be avoided.Of course, the use of the tracker makes the procedure
slightly more invasive. The implantation of the percutan-
eous pin, however, takes on only a few minutes and can
be performed under local anesthesia. In overweight or
obese people, however, it is often difficult to find the ap-
propriate foramen. Our patient was relatively thin, so we
cannot discuss how the technique would work in obese
patients. However, as the bony structures are the land-
marks for navigation, this technique should also be ap-
plicable with obese patients. Bending of the foramen
needle will cause problems in navigation, meaning that a
stiffer needle may be necessary.
Conclusions
As far we know, this is the first published tined lead im-
plantation which was guided based on the surgical navi-
gation and intraoperative O-arm images. The method is
slightly more invasive than the formal technique and
much trickier and expensive than fluoroscopy. However,
it could be an option in anatomically challenging cases
and reoperations. Overall, there is a place for this tech-
nique, but further studies are needed.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor of this journal.
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